BVS
Price:
$14.97
Market Cap:
$1.01B
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for p...[Read more]
Industry
Medical - Devices
IPO Date
2021-02-11
Stock Exchange
NASDAQ
Ticker
BVS
According to Bioventus Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 19.70. This represents a change of -18.82% compared to the average of 24.27 of the last 4 quarters.
The mean historical PE Ratio of Bioventus Inc. over the last ten years is -70.87. The current 19.70 PE Ratio has changed -2879.91% with respect to the historical average. Over the past ten years (40 quarters), BVS's PE Ratio was at its highest in in the December 2020 quarter at 65.25. The PE Ratio was at its lowest in in the December 2024 quarter at -1312.50.
Average
-70.87
Median
-11.15
Minimum
-667.01
Maximum
160.08
Discovering the peaks and valleys of Bioventus Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.01%
Maximum Annual PE Ratio = 160.08
Minimum Annual Increase = -321.26%
Minimum Annual PE Ratio = -667.01
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 21.88 | -208.37% |
| 2024 | -20.19 | 854.06% |
| 2023 | -2.12 | 110.02% |
| 2022 | -1.01 | -98.96% |
| 2021 | -96.60 | -321.26% |
| 2020 | 43.66 | -72.73% |
| 2019 | 160.08 | -283.33% |
| 2018 | -87.32 | -86.91% |
| 2017 | -667.01 | 1.01% |
| 2016 | -60.03 | 115.62% |
The current PE Ratio of Bioventus Inc. (BVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.14
5-year avg
-19.61
10-year avg
-70.87
Bioventus Inc.’s PE Ratio is greater than Treace Medical Concepts, Inc. (-4.90), greater than OrthoPediatrics Corp. (-12.83), greater than Standard BioTools Inc. (-3.16), greater than CeriBell, Inc. (-11.10), greater than Surmodics, Inc. (-58.88), greater than Butterfly Network, Inc. (-30.14), greater than Varex Imaging Corporation (-6.18), greater than Cytek Biosciences, Inc. (-7.38), greater than Avanos Medical, Inc. (-16.65), less than Semler Scientific, Inc. (184.82),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.90 | $308.15M | |
| -12.83 | $553.48M | |
| -3.16 | $310.27M | |
| -11.10 | $686.76M | |
| -58.88 | $614.51M | |
| -30.14 | $2.32B | |
| -6.18 | $519.40M | |
| -7.38 | $549.50M | |
| -16.65 | $1.17B | |
| 184.82 | $310.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioventus Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioventus Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bioventus Inc.'s PE Ratio?
How is the PE Ratio calculated for Bioventus Inc. (BVS)?
What is the highest PE Ratio for Bioventus Inc. (BVS)?
What is the 3-year average PE Ratio for Bioventus Inc. (BVS)?
What is the 5-year average PE Ratio for Bioventus Inc. (BVS)?
How does the current PE Ratio for Bioventus Inc. (BVS) compare to its historical average?